Minimal Impact of the COVID ‐19 Pandemic on Disease Activity and Health‐Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open‐Label Extension Study

C. Robinson, Philip; Machado, Pedro; Haroon, Nigil; S. Gensler, Lianne; D. Reveille, John; Taieb, V.; Vaux, T.; Fleurinck, C.; Oortgiesen, Marga; de Peyrecave, Natasha; Deodhar, Atul

doi:10.1002/acr2.11486

Public

Minimal Impact of the COVID ‐19 Pandemic on Disease Activity and Health‐Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open‐Label Extension Study

Published in ACR Open Rheumatology • Jul 14, 2022

Authors:

Philip C. Robinson

Pedro Machado

Nigil Haroon

Abstract

OBJECTIVE: The impact of the COVID-19 pandemic on patients with inflammatory rheumatic diseases, such as ankylosing spondylitis (AS), has been variable. Here, we assess disease activity and health-related quality of life (HRQoL) through the pandemic in patients with AS. METHODS: In the open-label ex...

Subject

Ankylosing spondylitis

Medicine

Pandemic

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!